Skip to content
800x129-purple-trans
  • Home
  • About Us
  • Technologies
    • Nanoclay Technologies
    • Papers & Publications
    • Stem Cell Products
  • Investors
  • News
  • Contact Us
  • Home
  • About Us
  • Technologies
    • Nanoclay Technologies
    • Papers & Publications
    • Stem Cell Products
  • Investors
  • News
  • Contact Us
800x129-purple-trans
  • Home
  • About Us
  • Technologies
    • Nanoclay Technologies
    • Papers & Publications
    • Stem Cell Products
  • Investors
  • News
  • Contact Us
  • Home
  • About Us
  • Technologies
    • Nanoclay Technologies
    • Papers & Publications
    • Stem Cell Products
  • Investors
  • News
  • Contact Us
800x129-purple-trans
  • Home
  • About Us
  • Technologies
    • Nanoclay Technologies
    • Papers & Publications
    • Stem Cell Products
  • Investors
  • News
  • Contact Us
  • Home
  • About Us
  • Technologies
    • Nanoclay Technologies
    • Papers & Publications
    • Stem Cell Products
  • Investors
  • News
  • Contact Us
800x129-purple-trans
  • Home
  • About Us
  • Technologies
    • Nanoclay Technologies
    • Papers & Publications
    • Stem Cell Products
  • Investors
  • News
  • Contact Us
  • Home
  • About Us
  • Technologies
    • Nanoclay Technologies
    • Papers & Publications
    • Stem Cell Products
  • Investors
  • News
  • Contact Us

Our nanoclay has been featured on the cover of Orthoworld’s Bonezone!

  • Posted on December 20, 2019
  • By Renovos Media Team
  • In Company News
Bonezone magazine

The synthetic nanoclay gel scaffold effectively localises new bone formation (in red). It offers injectable delivery and retention of biologics, released only to in-growing cells for efficacy at ultra-low doses without side effects.

Picture credit: Renovos/University of Southampton

The magazine can be found here: https://editions.mydigitalpublication.com/publication/?i=640056&ver=html5&p=1

Cover of Bonezone magazine featuring Renovos

FacebookTwitterLinkedIn
Innovation Challenge Finalist at RESI Boston
Previous
Renovos receives investment for nanoclay innovation from leading medical research charity Orthopaedic Research UK
Next
ORUK

Recent Posts

  • Renovos wins Innovate UK’s Biomedical Catalyst funding!
  • How Renovite nanoclays open up new opportunities in regenerative medicine
  • Nanoclays and regenerative medicine: a journey towards the clinic
  • Chemistry? Clays? Isn’t this a biologics company?
  • Renovos wins Innovate UK SMART grant

Renovos Biologics Ltd.
University of Southampton Science Park
2 Venture Road
Chilworth
Southampton SO16 7NP
United Kingdom

enquiries@renovos.co.uk

Research excellence in association with
the University of Southampton

  • Home
  • About Us
  • Technologies
    • Nanoclay Technologies
    • Papers & Publications
    • Stem Cell Products
  • Investors
  • News
  • Contact Us
×
  • Home
  • About Us
  • Technologies
    • Nanoclay Technologies
    • Papers & Publications
    • Stem Cell Products
  • Investors
  • News
  • Contact Us
600x97-renovos-logo-trans
Revolutionary platform technology, RENOVITE®, uses synthetic nanoclay gels to safely and precisely deliver therapeutic agents for regenerative medicine.
Linkedin Twitter Youtube

Renovos is a trading name of Renovos Biologics Limited, registered in England and Wales under company number 10685524.   Legal & Privacy

Copyright © Renovos 2022 / Images © Renovos Biologics Ltd Bone and Joint Research Group, University of Southampton / Website by Seajar Digital